INS and Hypoglycemia: Further, there was a greater odds of hypoglycemia associated with SBB vs. carvedilol in basal insulin non-users (OR 1.38, 95% CI 1.02–1.86, p = 0.03) but not in users (OR 0.84, 95% CI 0.52–1.36, p = 0.47).